BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 24613900)

  • 1. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
    Conte E; Gili E; Fagone E; Fruciano M; Iemmolo M; Vancheri C
    Eur J Pharm Sci; 2014 Jul; 58():13-9. PubMed ID: 24613900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
    Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
    PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
    Wu SB; Hou TY; Kau HC; Tsai CC
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration.
    Fagone E; Conte E; Gili E; Fruciano M; Pistorio MP; Lo Furno D; Giuffrida R; Crimi N; Vancheri C
    Exp Lung Res; 2011 Apr; 37(3):162-74. PubMed ID: 21269063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo.
    Ma Z; Zhao C; Chen Q; Yu C; Zhang H; Zhang Z; Huang W; Shen Z
    Pulm Pharmacol Ther; 2018 Dec; 53():100-106. PubMed ID: 30394340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
    Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
    Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
    Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
    Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
    Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib inhibits TGF-β-induced myofibroblast transdifferentiation in human Tenon's fibroblasts.
    Lin X; Wen J; Liu R; Gao W; Qu B; Yu M
    Mol Vis; 2018; 24():789-800. PubMed ID: 30636861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
    Choi K; Lee K; Ryu SW; Im M; Kook KH; Choi C
    Mol Vis; 2012; 18():1010-20. PubMed ID: 22550395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
    Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
    Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-β1-induced differentiation of atrial fibroblasts into myofibroblasts in vitro.
    Yang L; Hu J; Hao HZ; Yin Z; Liu G; Zou XJ
    Int J Mol Med; 2015 Apr; 35(4):1026-32. PubMed ID: 25647570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors.
    Didiasova M; Singh R; Wilhelm J; Kwapiszewska G; Wujak L; Zakrzewicz D; Schaefer L; Markart P; Seeger W; Lauth M; Wygrecka M
    FASEB J; 2017 May; 31(5):1916-1928. PubMed ID: 28148565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on differentiation from pulmonary fibroblast to myofibroblast mediated by Rho-associated coiled-coil forming protein kinase pathway].
    Yuan Y; Yang F; Xu H; Yu WY; Sun Y; Deng HJ; Ma WD; Wei ZQ; Wang RM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Sep; 31(9):654-60. PubMed ID: 24064119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2.
    Epa AP; Thatcher TH; Pollock SJ; Wahl LA; Lyda E; Kottmann RM; Phipps RP; Sime PJ
    PLoS One; 2015; 10(8):e0135266. PubMed ID: 26248335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
    Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
    Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.